1. Home
  2. PRPO vs BHST Comparison

PRPO vs BHST Comparison

Compare PRPO & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precipio Inc.

PRPO

Precipio Inc.

HOLD

Current Price

$19.02

Market Cap

38.3M

Sector

Industrials

ML Signal

HOLD

Logo BioHarvest Sciences Inc.

BHST

BioHarvest Sciences Inc.

SELL

Current Price

$1.44

Market Cap

33.1M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
PRPO
BHST
Founded
N/A
2007
Country
United States
Canada
Employees
N/A
89
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
38.3M
33.1M
IPO Year
2000
2017

Fundamental Metrics

Financial Performance
Metric
PRPO
BHST
Price
$19.02
$1.44
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $10.50
AVG Volume (30 Days)
★ 34.2K
14.2K
Earning Date
11-10-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 92.15
N/A
EPS
N/A
★ N/A
Revenue
★ $24,049,000.00
N/A
Revenue This Year
$233.72
$8.44
Revenue Next Year
$22.61
$32.53
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 29.77
N/A
52 Week Low
$17.79
$1.37
52 Week High
$33.63
$8.30

Technical Indicators

Market Signals
Indicator
PRPO
BHST
Relative Strength Index (RSI) 39.94 36.32
Support Level $19.37 $1.40
Resistance Level $24.78 $1.77
Average True Range (ATR) 1.01 0.12
MACD -0.04 -0.02
Stochastic Oscillator 37.67 0.00

Price Performance

Historical Comparison
PRPO
BHST

About PRPO Precipio Inc.

Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.

About BHST BioHarvest Sciences Inc.

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.

Share on Social Networks: